Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: A 24-month, randomized clinical trial

Eye

Volumn 25, Issue 12, 2011, Pages 1598-1606

  Cillino, S ^a   Di Pace, F ^a   Cillino, G ^a   Casuccio, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

adjuvants in trabeculectomy; mitomycin C; Ologen; trabeculectomy

Indexed keywords

ANTIGLAUCOMA AGENT; COLLAGEN IMPLANT; MITOMYCIN C; OLOGEN IMPLANT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; BIODEGRADABLE IMPLANT; CHOROID DETACHMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; LOW DRUG DOSE; MALE; OPEN ANGLE GLAUCOMA; PEROPERATIVE CARE; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDY; PSEUDOEXFOLIATION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TRABECULECTOMY;

EID: 83455186692     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.219     Document Type: Article

References (36)

1. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991; 109: 1693-1698.
2. Skuta GL, Beeson CC, Higginbotham EJ, Lichter PR, Musch DC, Bergstrom TJ et al. Intraoperative mitomycin vs postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992; 99: 438-444.
3. Smith MF, Doyle JW, Nguyen QH, Sherwood MB. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery. J Glaucoma 1997; 6: 104-110. (Pubitemid 27183194)
4. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surg Lasers 1998; 29: 428-431.
5. Membrey WL, Poinoosawmy DP, Bunce C, Hitchings RA. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications. Br J Ophthalmol 2000; 84: 586-590. (Pubitemid 30339307)
6. Singh K, Mehta K, Shaikh NM, Tsai JC, Moster MR, Budenz DL et al. Trabeculectomy with intraoperative mitomycin C vs 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 2000; 107: 2305-2309.
7. Yue J, Hu CQ, Lei XM, Qin GH, Zhang Y. Trabeculectomy with amniotic membrane transplantation and combining suture lysis of scleral flap in complicated glaucoma. Zhonghua Yan Ke Za Zhi 2003; 39: 476-480.
8. Cillino S, Zeppa L, Di Pace F, Casuccio A, Morreale D, Bocchetta F et al. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol 2008; 86: 314-321. (Pubitemid 351785105)
9. Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J, WuDunn D. Long-term outcomes of intraoperative 5-fluorouracil vs intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology 2009; 116: 185-190.
10. Wong TT, Khaw PT, Aung T, Foster PJ, Htoon HM, Oen FT et al. The Singapore 5-fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology 2009; 116: 175-184.
11. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98: 317-321.
12. Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N et al. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery. An evidence-based review. Ophthalmology 2002; 109: 2215-2224. (Pubitemid 35417101)
13. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2005; 4: CD002897.
14. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19: 442-450. (Pubitemid 40553146)
15. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 2006; 90: 175-180. (Pubitemid 43163847)
16. Hsu WC, Spilker MH, Yannas IV, Rubin PA. Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant. Invest Ophthalmol Vis Sci 2000; 41: 2404-2411. (Pubitemid 30624363)
17. Chen HS, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: an animal model. Invest Ophthalmol Vis Sci 2006; 47: 5310-5314. (Pubitemid 46723780)
18. Hsu WC, Ritch R, Krupin T, Chen HS. Tissue bioengineering for surgical bleb defects: an animal study. Graefes Arch Clin Exp Ophthalmol 2008; 246: 709-717.
19. Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant. Eur J Ophthalmol 2009; 19: 223-230.
20. Papaconstantinou D, Georgalas I, Karmiris E, Diagourtas A, Koutsandrea C, Ladas I et al. Trabeculectomy with OloGen vs trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol 2010; 88: 80-85.
21. Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS. A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye (Lond) 2010; 24: 1449-1457.
22. Stalmans I, Gillis A, Lafaut AS, Zeyen T. Safe trabeculectomy technique: long-term outcome. Br J Ophthalmol 2006; 90: 44-47. (Pubitemid 43029895)
23. Dhingra S, Khaw PT. The Moorfields safer surgery system. Middle East Afr J Ophthalmol 2009; 16: 112-115.
24. Cillino S, Di Pace F, Casuccio A, Lodato G. Deep sclerectomy vs punch trabeculectomy: effect of low-dosage mitomycin C. Ophthalmologica 2005; 219: 281-286. (Pubitemid 41208864)
25. Marquardt D, Lieb WE, Grehn F. Intensified postoperative care vs conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies. Graefes Arch Clin Exp Ophthalmol 2004; 242: 106-113. (Pubitemid 38324962)
26. Traverso CE, Greenidge KC, Spaeth GL, Wilson RP. Focal pressure: a new method to encourage filtration after trabeculectomy. Ophthalmic Surg 1984; 15: 62-65. (Pubitemid 14158788)
27. Wells AP, Ashraff NN, Hall RC, Purdie G. Comparison of two clinical Bleb grading systems. Ophthalmology 2006; 113: 77-83. (Pubitemid 43021731)
28. Kawana K, Kiuchi T, Yasuno Y, Oshika T. Evaluation of trabeculectomy blebs using 3-dimensional cornea and anterior segment optical coherence tomography. Ophthalmology 2009; 116: 848-855.
29. Singh M, See JL, Aquino MC, Thean LS, Chew PT. High-definition imaging of trabeculectomy blebs using spectral domain optical coherence tomography adapted for the anterior segment. Clin Exp Ophthalmol 2009; 37: 345-351.
30. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: 1491-1494.
31. Boey PY, Narayanaswamy A, Zheng C, Perera SA, Htoon HM, Tun TA et al. Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants. Br J Ophthalmol 2011; 95: 340-344.
32. Picht G, Grehn F. Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 1998; 9: 2-8. (Pubitemid 28284566)
33. Cantor LB, Mantravadi A, WuDunn D, Swamynathan K, Cortes A. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana Bleb Appearance Grading Scale. J Glaucoma 2003; 12: 266-271. (Pubitemid 36736730)
34. Lopes JF, Moster MR, Wilson RP, Altangerel U, Alvim HS, Tong MG et al. Subconjunctival sodium hyaluronate 2. 3% in trabeculectomy: a prospective randomized clinical trial. Ophthalmology 2006; 113: 756-760.
35. Cillino S, Di Pace F, Casuccio A, Calvaruso L, Morreale D, Vadalà M et al. Deep sclerectomy vs punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma 2004; 13: 500-506. (Pubitemid 39546345)
36. Cillino S, Di Pace F, Casuccio A, Cillino G, Lodato G. Deep sclerectomy vs trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica 2008; 222: 81-87. (Pubitemid 351311708)